|
|
|
|
| LEADER |
01056nam a2200253 u 4500 |
| 001 |
EB000942892 |
| 003 |
EBX01000000000000000736482 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 9781860163333
|
| 020 |
|
|
|a 1860163335
|
| 050 |
|
4 |
|a RC662.18
|
| 245 |
0 |
0 |
|a Type 2 diabetes
|h Elektronische Ressource
|b national clinical guideline for management in primary and secondary care (update)
|c The National Collaborating Centre for Chronic Conditions
|
| 260 |
|
|
|a London
|b Royal College of Physicians
|c 2008, 2008
|
| 300 |
|
|
|a viii, 279 p.
|b ill.
|c 28 cm
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Diabetes Mellitus, Type 2 / therapy
|
| 710 |
2 |
|
|a National Collaborating Centre for Chronic Conditions (Great Britain)
|
| 710 |
2 |
|
|a Royal College of Physicians of London
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK53885
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|